Table 2.

Descriptive baseline characteristics of included patients (n = 38)

Features	Value
Age	72.5 (66.5—81.0)
Gender, Male	27 (71.4%)
Body mass index, kg/m2	26.6 (24.0—29.1)
Charlson Comorbidity Index
0	21 (55.3%)
1	13 (34.2%)
2	3 (7.9%)
3	1 (2.6%)
Urine cytology
Non-diagnostic	13 (34.2%)
Negative	16 (42.1%)
Positive	9 (23.7%)
Previous endovescical treatment
Bacillus Calmette-Guerin	4 (10.5%)
Epirubicin	1 (2.6%)
Mitomycin C	3 (7.9%)
None	30 (78.9%)

Continuous variables are presented as median and interquartile ranges (IQR). Categorical variables are presented as frequencies and percentages (%)